| CACNA1G |
Homo sapiens |
|
CACNA1G is differentially expressed in 105 experiments [112 up/124 dn]: 43 organism parts: skeletal muscle [1 up/2 dn], cerebellum [2 up/0 dn], ...; 33 disease states: normal [4 up/2 dn], clear cell sarcoma of the kidney [1 up/0 dn], ...; 18 cell types, 23 cell lines, 22 compound treatments and 18 other conditions. |
| CACNA1G, KIAA1123 |
|
Cacna1g (Mus musculus)
CAC1G_RAT (Rattus norvegicus)
(Compare orthologs)
|
|
|
| Ion transport, Voltage-dependent calcium channel, T-type, alpha-1 subunit, Voltage-dependent calcium channel, alpha-1 subunit |
|
|
| artery smooth muscle contraction, calcium ion binding, calcium ion transport, elevation of cytosolic calcium ion concentration, low voltage-gated calcium channel activity |
|
|
|
O43497
Q19QZ6
Q19QZ7
Q19QZ9
Q19R01
Q19R03
Q19R05
Q19R07
Q19R09
Q2TAC4
Q19R18
Q19R17
Q19R16
Q19R15
Q19R13
Q19R12
Q19R11
Q19R10
Q19R08
Q19R06
Q19R04
Q19R02
Q19R00
Q19QZ8
|
|
|
|
ENSG00000006283
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
None
|
Compound treatment |
|
|
Normal
|
Disease state |
|
|
Stromal cell
|
Cell type |
|
|
Skeletal muscle
|
Organism part |
|
|
Uninfected
|
Infection |
|
|
Cerebellum
|
Organism part |
|
|
FLAP
|
Compound treatment |
|
|
PC3
|
Cell line |
|
|
MK886
|
Compound treatment |
|
|
Endothelial cell
|
Cell type |
|
|
Fibroblast
|
Cell type |
|
|
MDA-MB-231
|
Cell line |
|
|
HNRPA2B
|
Compound treatment |
|
|
Epithelial cell
|
Cell type |
|
|
Homo sapiens
|
Organism |
|
|
Normal
|
Histology |
|
|
Control
|
RNAi |
|
|
Wild_type
|
Genotype |
|
|
Cystic change
|
Histology |
|
|
Caudate nucleus
|
Organism part |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
White blood cells
|
Organism part |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
BT-474
|
Cell line |
|
|
Tumor
|
Organism part |
|
|
HPL1
|
Cell line |
|
|
A549
|
Cell line |
|
|
Superior cervical ganglion
|
Organism part |
|
|
Clear cell sarcoma of the kidn...
|
Disease state |
|
|
Anaplasma phagocytophilum
|
Infection |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
MCF10A
|
Cell line |
|
|
HaCaT
|
Cell line |
|
|
Spermatid
|
Cell type |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Methotrexate
|
Compound treatment |
|
|
Spermatocyte
|
Cell type |
|
|
Testis
|
Organism part |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Epilepsy
|
Disease state |
|
|
Macaca mulatta
|
Organism |
|
|
Heat-killed Anaplasma phagocyt...
|
Infection |
|
|
Trigeminal ganglion
|
Organism part |
|
|
MCF-7
|
Cell line |
|
|
Cartilage
|
Organism part |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Acute malaria, natural infecti...
|
Disease state |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Epidermal growth factor
|
Compound treatment |
|
|
HeLa
|
Cell line |
|
|
SIM2s
|
RNAi |
|
|
Seminiferous tubule
|
Organism part |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Wilms' tumor
|
Disease state |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Baseline uninfected
|
Disease state |
|
|
Enzo Labeling
|
Protocol type |
|
|
Grade IV
|
Tumor grading |
|
|
Beas2B
|
Cell line |
|
|
Lung
|
Organism part |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
Smooth muscle
|
Organism part |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
Glioblastoma
|
Disease state |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
CodeLink Labeling
|
Protocol type |
|
|
Placebo
|
Compound treatment |
|
|
Glutamine
|
Compound treatment |
|
|
Primary fibroblast
|
Cell type |
|
|
Experimental malaria-infected
|
Disease state |
|
|
Subthalamic nucleus
|
Organism part |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
Serum starvation synchronizati...
|
Growth condition |
|
|
Hydrogen peroxide
|
Compound treatment |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Thymus
|
Organism part |
|
|
Globus pallidus
|
Organism part |
|
|
Stage II
|
Disease staging |
|
|
Not applicable
|
Histology |
|
|
Breast carcinoma
|
Disease state |
|
|
CADO ES1
|
Cell line |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
Whole blood
|
Organism part |
|
|
Met5A
|
Cell line |
|
|
Empty vector
|
Gene modification |
|
|
Skin
|
Organism part |
|
|
BT474
|
Cell line |
|
|
Cigarette smoke
|
Growth condition |
|
|
Incubator control
|
Growth condition |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Capra hircus
|
Organism |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
Trichostatin A
|
Compound treatment |
|
|
XBP1 overexpression
|
Genotype |
|
|
YCC16
|
Cell line |
|
|
B-precursor acute lymphoblasti...
|
Disease state |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
Huntington's disease
|
Disease state |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Thalamus
|
Organism part |
|
|
Pan troglodytes
|
Organism |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Atrioventricular node
|
Organism part |
|
|
Leydig cell
|
Cell type |
|
|
Primary
|
Disease staging |
|
|
Muscle invasive carcinoma
|
Disease state |
|
|
HL60 cell lysate
|
Infection |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Oligodendroglioma
|
Disease state |
|
|
Blood
|
Organism part |
|
|
Umbilical cord
|
Organism part |
|
|
Fetus
|
Developmental stage |
|
|
Adult
|
Developmental stage |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
CD3+ CD4+ CD8- CD45RA+ CD62L+
|
Phenotype |
|
|
Naive T cell
|
Cell type |
|
|
AdERb high moi
|
Gene modification |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Measles virus Chicago-1 strain
|
Infection |
|
|
10 ng/ml LPS in media
|
Growth condition |
|
|
Ciliary ganglion
|
Organism part |
|
|
Granulocyte macrophage-colony ...
|
Compound treatment |
|
|
Plasma cell leukemia
|
Disease state |
|
|
N/a
|
Test result |
|
|
Non-ischemic cardiomyopathy
|
Disease state |
|
|
ERalpha/beta transfected
|
Genotype |
|
|
Entorhinal cortex
|
Organism part |
|
|
MiR15a/miR16-1 transfection
|
Gene modification |
|
|
Media only
|
Growth condition |
|
|
A. fumigatus condia in media
|
Growth condition |
|
|
Cancer21
|
Replicate |
|
|
T84
|
Cell line |
|
|
Caco-2
|
Cell line |
|
|
Cancer14
|
Replicate |
|
|
MCF7
|
Cell line |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Salivary gland
|
Organism part |
|
|
LEDGF knockdown
|
RNAi |
|
|
Pons
|
Organism part |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Cerebellum peduncles
|
Organism part |
|
|
CD34+
|
Cell type |
|
|
Filtered air
|
Compound treatment |
|
|
Down syndrome
|
Disease state |
|
|
Benign
|
Disease staging |
|
|
Normal
|
Disease staging |
|
|
Ovary
|
Organism part |
|
|
Treated malaria, natural infec...
|
Disease state |
|
|
PML/RAR
|
Genotype |
|
|
Lymph node
|
Organism part |
|
|
Fetal lung
|
Organism part |
|
|
ERalpha transfected
|
Genotype |
|
|
SNU16
|
Cell line |
|
|
HL-60
|
Cell line |
|
|
Lymphoid tissue
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
Normal
|
Clinical history |
|
|
Primary visual cortex
|
Organism part |
|
|
Parietal lobe
|
Organism part |
|
|
Staphylococcus aureus
|
Infection |
|
|
Aggregatibacter actinomycetemc...
|
Infection |
|
|
Gastric adenocarcinoma
|
Disease state |
|
|
Cyclosporin A, mycophenolate m...
|
Clinical treatment |
|
|
Sirolimus, mycophenolate mofet...
|
Clinical treatment |
|
|
Pancreas
|
Organism part |
|
|
Fibromuscular tissue from endo...
|
Organism part |
|
|
T-cell lymphoblastic lymphoma
|
Disease state |
|
|
Placenta
|
Organism part |
|
|
Psoriatic lesional biopsy
|
Clinical info |
|
|
Uninvolved biopsy
|
Clinical info |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Malignant melanoma
|
Disease state |
|
|
Arsenic oxide
|
Compound treatment |
|
|
Trachea
|
Organism part |
|
|
Heregulin
|
Compound treatment |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
BDCA1+ dendritic cell
|
Cell type |
|
|
Ewing family tumor
|
Disease state |
|
|
Neuroblastoma
|
Disease state |
|
|
Spinal cord
|
Organism part |
|
|
Grade III
|
Tumor grading |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
Cigarette smoke
|
Compound treatment |
|
|
Acute radiation toxicity
|
Clinical history |
|
|
Valproic acid
|
Compound treatment |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Dorsal root ganglion
|
Organism part |
|
|
Rapamycin
|
Compound treatment |
|
|
|
|
|
Processing time: 0.156 secs.